Literature DB >> 2801672

Bone involvement in primary hemochromatosis and alcoholic cirrhosis.

D Conte1, M P Caraceni, J Duriez, C Mandelli, E Corghi, M Cesana, S Ortolani, P A Bianchi.   

Abstract

Biochemical indexes of bone metabolism, bone mineral density, and histomorphometry were evaluated in 14 male patients with noncholestatic cirrhosis due to primary hemochromatosis (six cases) or to chronic alcohol abuse (eight cases), and in 30 male controls of similar age. Alkaline phosphatase in alcoholic patients was significantly higher than in controls (mean +/- SD 50.4 +/- 33.7 vs 33.0 +/- 7.1 U/L, p less than 0.01), as was urinary hydroxyproline in both hemochromatotics and alcoholics (mean +/- SD, 44.3 +/- 8.4 and 40.4 +/- 16.8, respectively, vs 30.1 +/- 4.5 mg/g, p less than 0.001 and p less than 0.005). Bone mineral density was significantly lower in hemochromatotics than in alcoholics and controls (mean +/- SD, 591 +/- 90 vs 765 +/- 87 and 759 +/- 34 mg/cm2, respectively, p less than 0.005 and p less than 0.001). At bone biopsy, trabecular osteoporosis was observed in two hemochromatotics and four alcoholics, and osteomalacia was seen in another alcoholic. Overall densitometric and histomorphometric findings indicate a derangement of trabecular bone in both alcoholic and hemochromatotic cirrhosis, whereas cortical osteoporosis seems limited to hemochromatotic patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2801672

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  Bone status in a mouse model of genetic hemochromatosis.

Authors:  P Guggenbuhl; P Fergelot; M Doyard; H Libouban; M-P Roth; Y Gallois; G Chalès; O Loréal; D Chappard
Journal:  Osteoporos Int       Date:  2010-10-26       Impact factor: 4.507

2.  Iron accumulation in tissues of magnesium-deficient rats with dietary iron overload.

Authors:  M Kimura; K Yokoi
Journal:  Biol Trace Elem Res       Date:  1996-02       Impact factor: 3.738

Review 3.  Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature.

Authors:  Nicholas G Angelopoulos; Anastasia K Goula; George Papanikolaou; George Tolis
Journal:  Osteoporos Int       Date:  2005-07-05       Impact factor: 4.507

4.  Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

Authors:  Ingolf Schiefke; Andreas Fach; Marcus Wiedmann; Andreas-V Aretin; Eva Schenker; Gudrun Borte; Manfred Wiese; Joachim Moessner
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

5.  MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease.

Authors:  Rebecca Mitchell; Jill McDermid; Mang M Ma; Constance L Chik
Journal:  World J Hepatol       Date:  2011-06-27

6.  Spontaneous multiple vertebral fractures revealed primary haemochromatosis.

Authors:  M Duquenne; V Rohmer; E Legrand; D Chappard; N Wion Barbot; M F Basle; M Audran; J C Bigorgne
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

7.  Bone mineral density in men with genetic hemochromatosis and HFE gene mutation.

Authors:  P Guggenbuhl; Y Deugnier; J F Boisdet; Y Rolland; A Perdriger; Y Pawlotsky; G Chalès
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

8.  Association between iron overload and osteoporosis in patients with hereditary hemochromatosis.

Authors:  L Valenti; M Varenna; A L Fracanzani; V Rossi; S Fargion; L Sinigaglia
Journal:  Osteoporos Int       Date:  2008-07-26       Impact factor: 4.507

Review 9.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

10.  Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia.

Authors:  Sittisak Honsawek; Tawatchai Chaiwatanarat; Paisarn Vejchapipat; Voranush Chongsrisawat; Nutchanart Thawornsuk; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2009-01-29       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.